-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MMoFxfS4Kq6sk6epevHz/yFJ5sitBxXtqW+qAezv7PjXDhh1/Qh43uzCHQ3nn0BM Hc/z9KLWd7t0EqW0sXDt1g== 0001144204-08-067032.txt : 20081128 0001144204-08-067032.hdr.sgml : 20081127 20081126174503 ACCESSION NUMBER: 0001144204-08-067032 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20081128 DATE AS OF CHANGE: 20081126 GROUP MEMBERS: BORIS SKURKOVICH GROUP MEMBERS: CAROL DORROS GROUP MEMBERS: CHRISTOPHER W. CAPPS GROUP MEMBERS: DAVID W. VALENTINE GROUP MEMBERS: JOHN R. CAPPS (AND DEBBIE CAPPS) GROUP MEMBERS: JULIA K. GLUCK GROUP MEMBERS: MATTHEW GOOCH GROUP MEMBERS: MICHAEL P. KRASNY REVOCABLE TRUST, MICHAEL KRASNY TRUSTEE GROUP MEMBERS: REBECCA S. KIPHART GROUP MEMBERS: SIMON V. SKURKOVICH SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADVANCED BIOTHERAPY INC CENTRAL INDEX KEY: 0000791833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 510402415 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-81621 FILM NUMBER: 081219035 BUSINESS ADDRESS: STREET 1: 227 WEST MONROE STREET 2: SUITE 3900 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-701-0793 MAIL ADDRESS: STREET 1: 227 WEST MONROE STREET 2: SUITE 3900 CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED BIOTHERAPY CONCEPTS INC DATE OF NAME CHANGE: 19990524 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KIPHART RICHARD P CENTRAL INDEX KEY: 0000904775 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: C/O WILLIAM BLAIR &COMPANY, LLC STREET 2: 222 WEST ADAMS STREET CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312 MAIL ADDRESS: STREET 1: C/O WILLIAM BLAIR &COMPANY, LLC STREET 2: 222 WEST ADAMS STREET CITY: CHICAGO STATE: IL ZIP: 60606 SC 13D 1 v133549_sc13d.htm Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No 3 with respect to Richard P. Kiphart)
(Amendment No 1 with respect to Michael P. Krasny)
 
ADVANCED BIOTHERAPY, INC.
(Name of Issuer)
 
Common Stock, par value $0.001
(Title of Class of Securities)
 
00750J100
(CUSIP Number)
 
Christopher W. Capps
227 West Monroe, Suite 3900, Chicago, IL 60606
(312) 701-0793
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
November 18, 2008
(Date of Event Which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.o
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.
 
(Page 1 of 6 Pages)
 
 
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Richard P. Kiphart
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
954,921,582
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
954,921,582
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
954,921,582
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
81.64%
(14) Type of Reporting Person (See Instructions)
 
IN

2
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Michael P. Krasny Revocable Trust, Michael Krasny Trustee
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
62,052,200
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
62,052,200
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
62,052,200
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
5.31%
(14) Type of Reporting Person (See Instructions)
 

OO
 
3
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Simon V. Skurkovich
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
13,878,840
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
13,878,840
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
13,878,840
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
1.18%
(14) Type of Reporting Person (See Instructions)
 
IN
 
4
 
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Rebecca S. Kiphart
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
6,666,666
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
6,666,666
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
6,666,666
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
.57%
(14) Type of Reporting Person (See Instructions)
 
IN

5
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Julia K. Gluck
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
6,666,666
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
6,666,666
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
6,666,666
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
.57%
(14) Type of Reporting Person (See Instructions)
 
IN

6
 
 
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. John R. Capps (and Debbie Capps)
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
4,000,000
(8) Shared Voting Power
 
3,333,333
(9) Sole Dispositive Power
 
4,000,000
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
7,333,333
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
.63%
(14) Type of Reporting Person (See Instructions)
 
IN
 
7
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Matthew Gooch
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
7,333,333
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
7,333,333
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
7,333,333
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
.63%
(14) Type of Reporting Person (See Instructions)
 
IN
 
8
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. David W. Valentine
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
7,333,333
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
7,333,333
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
7,333,333
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
.63%
(14) Type of Reporting Person (See Instructions)
 
IN
 
9
 
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Christopher W. Capps
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
21,333,334
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
21,333,334
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
21,333,334
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
1.79%
(14) Type of Reporting Person (See Instructions)
 
IN

10
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Boris Skurkovich
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
11,961,709
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
11,961,709
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
11,961,709
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
1.01%
(14) Type of Reporting Person (See Instructions)
 
IN

11
 
CUSIP No. 00750J100
 
  
(1) Names of reporting persons. Carol Dorros
I.R.S. Identification Nos. of above persons (entities only)
 
  
(2) Check the appropriate box if a member of a group (see instructions)
 
(a) £
(b) S
(3) SEC use only
 
  
(4) Source of funds (see instructions) NOT APPLICABLE
 
  
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)......£
 
  
(6) Citizenship or place of organization...........United States
 
  
 
  
 
Number of
Shares Bene-
ficially Owned
by Each
Reporting
Person With
(7) Sole Voting Power
 
2,765,555
(8) Shared Voting Power
 
None
(9) Sole Dispositive Power
 
2,765,555
(10) Shared Dispositive Power
 
None
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
 
2,765,555
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
¨
(13) Percent of Class Represented by Amount in Row (11)
 
.24%
(14) Type of Reporting Person (See Instructions)
 
IN
 
12
 
Item 1. Security and Issuer 

This statement relates to common stock, par value $0.001 (“Common Stock”), of Advanced Biotherapy, Inc. (the “Company”). The principal executive offices of the Company are located at 227 West Monroe, Suite 3900, Chicago, IL 60606.

Item 2. Identity and Background

This statement is being filed by the following persons (the “Reporting Persons”): Richard P. Kiphart, Michael P. Krasny Revocable Trust, Michael Krasny Trustee, Simon V. Skurkovich, Rebecca S. Kiphart, Julia K. Gluck, John R. Capps (and Debbie Capps), Matthew Gooch, David W. Valentine, Christopher W. Capps, Boris Skurkovich and Carol Dorros.

During the past five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors)

During the past five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which he was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Richard P. Kiphart: Mr. Kiphart is a principal of William Blair & Company, L.L.C., a broker dealer and investment adviser. Mr. Kiphart is a US citizen. The business address of Mr. Kiphart is as follows:

Richard P. Kiphart
c/o William Blair & Company, L.L.C.
222 West Adams Street
Chicago, IL 60606

Michael P. Krasny Revocable Trust, Michael Krasny Trustee: Said trust is organized under the laws of the State of Illinois. The business address of said trust is as follows:

Michael P. Krasny
c/o Sawdust Investment Management Corp.
6122 Willow Road, Suite 200
Northfield, IL 60093

Simon V. Skurkovich: Simon V. Skurkovich is a retired physician and was the founder of the predecessor company of Advanced Biotherapy, Inc. Simon V. Skurkovich is a US citizen. The home address of Simon V. Skurkovich is as follows:

Simon V. Skurkovich, M.D.
802 Rollins Avenue
Rockville, MD 20852

Rebecca S. Kiphart: Ms. Kiphart is a student and yoga instructor. Ms. Kiphart is a US citizen. The home address of Ms. Kiphart is as follows:

Rebecca S. Kiphart
1632 North Bissell, Apt. E
Chicago, IL 60614

13

Julia K. Gluck: Julia K. Gluck is a housewife. Julia K. Gluck is a US citizen. The home address of Julia K. Gluck is as follows:

Julia Gluck
985 Forest Ave.
Glencoe, IL 60022

John R. Capps: John R. Capps is a principal of Asbury Automotive St. Louis, LLC, a Delaware limited liability company d/b/a Plaza Motor Company. John R. Capps is a U.S. citizen. The business address of Mr. Capps is as follows:

John R. Capps
c/o Plaza Motor Company
11830 Olive Blvd.
St. Louis, Missouri 63141

Matthew Gooch: Matthew Gooch is a partner in William Blair & Co., L.L.C., a Delaware limited liability company. Matthew Gooch is a US citizen. The business address of Matthew Gooch is as follows:

Matthew Gooch
c/o William Blair & Company, L.L.C.
222 West Adams Street
Chicago, IL 60606

David W. Valentine: David W. Valentine is a partner in Victory Park Capital Advisors, LLC, a Delaware limited liability company. David W. Valentine is a US citizen. The business address of David W. Valentine is as follows:

David Valentine
c/o Victory Park Capital
227 West Monroe Street
Suite 3900
Chicago, IL 60606

Christopher W. Capps: Christopher W. Capps is the Chief Executive Officer of Advanced Biotherapy, Inc., a Delaware corporation. Christopher W. Capps is a US citizen. The business address of Christopher W. Capps is as follows:

Christopher W. Capps
227 West Monroe Street
Suite 3900
Chicago, IL 60606

Boris Skurkovich: Boris Skurkovich is a physician affiliated with Rhode Island Hospital. Boris Skurkovich is a US citizen. The business address of Boris Skurkovich is as follows:

Boris Skurkovich, MD
Division of Pediatric Infectious Diseases
Rhode Island Hospital
593 Eddy St. Providence, RI 02903

14

Carol Dorros: Carol Dorros is a physician. Carol Dorros is a US citizen. The home address of Carol Dorros is as follows:

Carol Dorros, M.D.
18 Blaisdell Avenue
Pawtucket, RI 02860
 
Item 3. Source and Amount of Funds or Other Consideration 
 
Not applicable.

Item 4. Purpose of Transaction 

On November 18, 2008, the Reporting Persons entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Lime Energy Co. to sell a total of 1,060,421,884 shares of the Common Stock of the Company in exchange for 2,252,341 shares of Lime’s common stock, par value $0.0001 per share. The description of the Purchase Agreement contained in this Schedule 13D is qualified in its entirety by reference to such agreement, which is incorporated by reference to Exhibit 1 hereto.
 
The purpose of the Purchase Agreement was to transfer control of the Company to Lime.
 
The acquisition by Lime under the Purchase Agreement is subject to the approval of Lime’s stockholders under the NASDAQ Marketplace Rules. Mr. Kiphart’s son-in-law, David W. Valentine, a Reporting Person, is also selling his Company stock to Lime under the Purchase Agreement, and he serves as a director and stockholder of both Lime and the Company.
 
The Reporting Persons expect to consummate their sale of their shares of Common Stock of the Company at least twenty days after Lime sends an information statement relating to the Purchase Agreement to its stockholders. As a result of that sale, Lime will hold approximately 90.8% of the outstanding common stock of the Company. Promptly following the closing of this acquisition, which is expected to occur during the first quarter of 2009, Lime has informed the Reporting Persons that Lime intends to effect a short-form merger with a wholly owned subsidiary of Lime and the Company whereby the separate corporate existence of the Company will terminate and each of the outstanding shares of the Common Stock of the Company not already owned by Lime shall be converted into 0.002124 shares of Lime’s common stock, which is the same exchange ratio under the Purchase Agreement. Lime has informed the Reporting Persons that Lime intends to file a Form S-4 registration statement with respect to the shares of Common Stock to be offered to the Company stockholders. Following the short-form merger, the registration of the Company’s common stock will terminate under the Securities Exchange Act and the common stock will no longer be publicly traded on the OTC Bulletin Board or elsewhere.
 
The terms of the Purchase Agreement require that Lime shall use its best efforts to cause Christopher Capps, a Reporting Person, to be appointed to the board of directors of Lime.
 
Except as set forth above, none of the Reporting Persons have any plans or proposals that would relate to or would result in any of the matters referred to in paragraphs (a) through (j) of Item 4 of Schedule 13D.
 
Item 5. Interest in Securities of the Issuer. 
 
a.
As of November 18, 2008, Richard P. Kiphart beneficially owned 954,921,582 shares of the common stock of the Company, consisting of 952,846,582 outstanding shares and 2,075,000 shares issuable pursuant to stock options held by Mr. Kiphart. The 954,921,582 shares equal 81.64% of the outstanding shares of common stock.

15
 
As of November 18, 2008, Michael Krasny beneficially owned 62,052,200 shares of the common stock of the Company, consisting of 62,052,200 outstanding shares. The 62,052,200 shares equal 5.31% of the outstanding shares of common stock.
 
As of November 18, 2008, Simon Skurkovich, M.D., beneficially owned 13,878,840 shares of the common stock of the Company, consisting of 10,260,840 outstanding shares and 3,618,000 shares issuable pursuant to stock options held by Dr. Skurkovich. The 13,878,840 shares equal 1.18% of the outstanding shares of common stock.
 
As of November 18, 2008, Rebecca S. Kiphart beneficially owned 6,666,666 shares of the common stock of the Company, consisting of 6,666,666 outstanding shares. The 6,666,666 shares equal .57% of the outstanding shares of common stock.
 
As of November 18, 2008, Julia K. Gluck beneficially owned 6,666,666 shares of the common stock of the Company, consisting of 6,666,666 outstanding shares. The 6,666,666 shares equal .57% of the outstanding shares of common stock.
 
As of November 18, 2008, John R. Capps beneficially owned 7,333,333 shares of the common stock of the Company, consisting of 3,333,333 outstanding shares and 4,000,000 shares issuable pursuant to stock options held by Mr. Capps. The 7,333,333 shares equal .63% of the outstanding shares of common stock.
 
As of November 18, 2008, Matthew Gooch beneficially owned 7,333,333 shares of the common stock of the Company, consisting of 3,333,333 outstanding shares and 4,000,000 shares issuable pursuant to stock options held by Mr. Gooch. The 7,333,333 shares equal .63% of the outstanding shares of common stock.
 
As of November 18, 2008, David Valentine beneficially owned 7,333,333 shares of the common stock of the Company, consisting of 3,333,333 outstanding shares and 4,000,000 shares issuable pursuant to stock options held by Mr. Valentine. The 7,333,333 shares equal .63% of the outstanding shares of common stock.
 
As of November 18, 2008, Christopher R. Capps beneficially owned 21,333,334 shares of the common stock of the Company, consisting of 2,666,667 outstanding shares and 18,666,667 shares issuable pursuant to stock options held by Mr. Capps. The 21,333,334 shares equal 1.79% of the outstanding shares of common stock.
 
As of November 18, 2008, Boris Skurkovich, M.D. beneficially owned 11,961,709 shares of the common stock of the Company (including 3,911,325 outstanding shares in the name of Samuel Skurkovich, his minor child), consisting of 6,496,709 outstanding shares and 5,465,000 shares issuable pursuant to stock options held by Dr. Skurkovich. The 11,961,709 shares equal 1.01% of the outstanding shares of common stock.
 
As of November 18, 2008, Carol Dorros, M.D. beneficially owned 2,765,555 shares of the common stock of the company, consisting of 2,765,555 outstanding shares. The 2,765,555 shares equal .24% of the outstanding shares of common stock.
 
b.
Each of the Reporting Persons beneficially owned the number of shares of Common Stock set forth in Item 5(a) over which such Reporting Person, except for John R. Capps, holds sole power to vote or direct the vote and sole power to dispose or to direct the disposition. John R. Capps shares the power to vote or direct the vote and shares the power to dispose or direct the disposition of his outstanding shares with his wife, Debbie Capps.
 
16

c.
On November 11, 2008, the Issuer re-priced all stock options granted during 2006 and 2007 to set the exercise price per share at $0.007 per share and amended the exercise period of such stock options to 18 months post termination as a service provider to Issuer. Reporting Persons Simon Skurkovich and Boris Skurkovich were the only Reporting Persons affected by the amendment regarding 2006 stock option grants. Reporting Persons John R. Capps, Richard P. Kiphart, David Valentine, Boris Skurkovich, Christopher W. Capps and Matthew Gooch were the only Reporting Persons affected by the amendment regarding 2007 stock option grants.
 
The Issuer further amended the stock options granted in November 2007 to Reporting Person Christopher W. Capps to purchase 50,000,000 shares (vesting over 3 years beginning 11/21/2008) to vest immediately upon the termination of his employment with the Company, and to amend the exercise period of such stock options to 18 months post-termination as a service provider.
 
Also on November 11, 2008, the Issuer granted each director of the Company, other than Richard P. Kiphart, stock options to purchase 2,000,000 shares of common stock at an exercise price per share of $0.007, with a term of 10 years and the right to exercise options for 12 months post-termination of services. This stock option grant by the Issuer affected Reporting Persons Christopher W. Capps, John R. Capps, Matthew Gooch, Boris Skurkovich and David Valentine.
 
d.
Not applicable.
 
e.
Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. 
 
Mr. Kiphart is a director and Chairman of Lime and its largest stockholder, and he is also a director and Chairman of the Company and its largest stockholder. Mr. Valentine is also a director and stockholder of both Lime and the Company. Mr. Valentine is a party to the Purchase Agreement. Lime has agreed to pay the legal fees of Mr. Kiphart in his capacity as the representative of the sellers under the Purchase Agreement. Christopher W. Capps is the son of John R. Capps, and Boris Skurkovich is the son of Simon Surkovich.
 
Except as set forth in this Schedule 13D, to the knowledge of the Reporting Persons, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2, and between such persons and any person with respect to any securities of the Company, including but not limited to, transfer or voting of any of the securities of the Company, finders fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies, or a pledge or contingency the occurrence of which would give another person voting power over the securities of the Company.
 
Item 7. Material to be Filed as Exhibits.

1.
Exhibit 1 – Stock Purchase Agreement dated as of November 18, 2008, by and among Lime Energy Co. and the Reporting Persons
 
2.
Exhibit 2 – Agreement among the Reporting Persons relating to Joint Filing dated as of November 25, 2008
 
17

Signature. 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
November 25, 2008
Date
/s/ Richard P. Kiphart
Signature

Name/Title: Richard P. Kiphart

/s/ Michael P. Krasny, Trustee
Signature

Name/Title: Michael P. Krasny, Trustee of the Michael P. Krasny Revocable Trust

/s/ Simon Skurkovich
Signature

Name/Title: Simon Skurkovich, M.D.

/s/ Rebecca S. Kiphart
Signature

Name/Title: Rebecca S. Kiphart

/s/ Julia K. Gluck
Signature

Name/Title: Julia K. Gluck

/s/ John R. Capps
Signature

Name/Title: John R. Capps

/s/ Mathew Gooch
Signature

Name/Title: Matthew Gooch

/s/ David W. Valentine
Signature

Name/Title: David W. Valentine

18

/s/ Christopher W. Capps
Signature

Name/Title: Christopher W. Capps
/s/ Boris Skurkovich
Signature

Name/Title: Boris Skurkovich, M.D.

/s/ Carol Dorros
Signature

Name/Title: Carol Dorros, M.D.

19
 
 EX-1 2 v133549_ex1.htm
STOCK PURCHASE AGREEMENT
 
     This Stock Purchase Agreement (this “Agreement”) is made and entered into as of November 18, 2008, by and among: Lime Energy Co., a Delaware corporation (“Lime”), and certain stockholders of Advanced Biotherapy, Inc., a Delaware corporation (the “Company”) listed in Schedule A (each a “Seller,” collectively the “Sellers”).
 
Recitals
 
     A.  The Sellers are holders of outstanding shares of common stock, par value $0.001 per share (“Company Common Stock”) of the Company and each Seller is the record holder and has sole voting power over such number of shares of Company Common Stock as is set forth opposite such Seller’s name on Schedule A  (the “Shares”).
 
     B. Lime desires to purchase from Sellers and Sellers desire to sell to Lime, all of the Shares owned by Sellers, in exchange for shares of Lime’s common stock, par value $0.0001 per share (the “Lime Common Stock”) at an exchange ratio (the “Exchange Ratio”) set forth on Schedule B (the “Transaction”).
 
     C. Under the Marketplace Rules of The NASDAQ Stock Market, Inc. (the “Marketplace Rules”), the issuance of the Lime Common Stock pursuant to the Transaction requires the approval of the stockholders holding at least a majority of the outstanding stock of Lime (the “Required Approval”).
 
     D. Lime intends to obtain the necessary approval of its stockholders by written consent in lieu of meeting. To be effective, such approval must be communicated to all of the Lime’s stockholders through an information statement (the “Information Statement”) pursuant to Section 14(c) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (collectively, the “Exchange Act”).
 
     E. Immediately after the closing of the Transaction, Lime will be the beneficial holder of 90% or more of the issued and outstanding Company Common Stock.
     NOW, THEREFORE, in consideration of the mutual benefits to be derived from this Agreement and of the representations, warranties, conditions, agreements and promises contained in this Agreement, the parties agree as follows:
 
ARTICLE 1
DEFINITIONS
 
     Certain capitalized terms used in this Agreement have the meanings set forth below and other capitalized terms used in this Agreement are defined in the Sections of this Agreement where they first appear. All capitalized terms shall be equally applicable to both the singular and plural forms. Any agreement referred to below shall mean such agreement as amended, supplemented and modified from time to time to the extent permitted by the applicable provisions thereof and by this Agreement.
 
     “Affiliate” shall mean, with respect to a Person, any other Person that, directly or indirectly, Controls, is Controlled by or is under common Control with such Person. The term “Affiliated” has the meaning correlative to the foregoing.
 
 
“Consent” shall mean any approval, consent, ratification, permission, waiver or authorization from or by a Governmental Body including any governmental authorization in the form of (a) permit, license, certificate, franchise, permission, variance, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Legal Requirement; or (b) right under any contract with any Governmental Body.
 
“Control,” “Controlled,” “Controlling” or “under common Control with” with respect to any Person, means having the ability to direct the management and affairs of such Person, whether through the ownership of voting securities, by contract or otherwise, and such ability shall be deemed to exist when a Person holds at least 50% of the outstanding voting securities of such Person.
 
“Entity” shall mean any corporation (including any non-profit corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock company), firm, society or other enterprise, association, organization or entity.
 
“GAAP” shall mean generally accepted accounting principles for financial reporting in the United States, applied on a basis consistent with the basis on which the financial statements referred to herein were prepared.
 
“Governmental Body” shall mean any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; or (c) governmental or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, instrumentality, official, organization, unit, body or Entity and any court or other tribunal).
 
“Indemnification Agreement” refers to the agreements between the Company and certain of its officers and directors, copies of which have been provided to Lime.
 
“Legal Requirement” shall mean any federal, state, local, municipal, foreign or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of any national securities exchange on which Lime Common Stock is listed). Reference to any Legal Requirement means such Legal Requirement as amended, modified, codified, replaced or reenacted, in whole or in part, and in effect from time to time, and reference to any section or other provision of any Legal Requirement means that provision of such Legal Requirement from time to time in effect and constituting the substantive amendment, modification, codification, replacement or reenactment of such section or other provision.
 
“Lien” shall mean any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, claim, infringement, interference, option, right of first refusal, equitable interest, title retention or title reversion agreement, preemptive right, community property interest or restriction of any nature, whether accrued, absolute, contingent or otherwise (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset).
 
“Lime Purchaser” shall mean either Lime or a wholly-owned Subsidiary of Lime, as determined by Lime in its sole discretion.
 
 
“Lime Shares” shall mean the number of shares of Lime Common Stock to be issued to the Sellers upon the terms and subject to the conditions set forth in this Agreement.
 
“Losses” shall mean damages, liabilities, losses, claims, diminution in value, obligations, liens, assessments, judgments, Taxes, fines, penalties, reasonable costs and expenses (including, without limitation, reasonable fees of counsel) and including all amounts paid in investigation, defense or settlement of the foregoing.
 
“Merger” shall mean the merger following the Closing of the Company with and into Lime, the Lime Purchaser or a wholly-owned Subsidiary of Lime not the Lime Purchaser, in accordance with Section 253 of the Delaware General Corporation Law
 
“Organizational Documents” shall mean an Entity’s certificate or articles of incorporation and bylaws (in the case of a corporation) and similar organizational documents (in the case of other types of Entities).
 
“Person” shall mean any individual, Entity or Governmental Body.
 
“Representatives” shall mean any party’s respective directors, officers, employees, investment bankers, attorneys, accountants or other advisors or representatives.
 
“SEC” shall mean the United States Securities and Exchange Commission.
 
“SEC Reports” shall mean the reports, registration statements and definitive proxy statements filed by an issuer with the SEC. “Company SEC Reports” shall refer to the SEC Reports filed by the Company and “Lime SEC Reports” shall refer to the SEC Reports filed by Lime.
 
“Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
 
An Entity shall be a “Subsidiary” of another Person if such Person directly or indirectly owns, beneficially or of record, (a) an amount of voting securities of other interests in such Entity that is sufficient to enable such Person to elect at leased a majority of the members of such Entity’s board of directors or other governing body, or (b) at least 50% of the outstanding equity or membership interests of such Entity.
 
“Tax” shall mean any tax (including any income tax, franchise tax, capital gains tax, gross receipts tax, value-added tax, surtax, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, withholding tax or payroll tax), levy, assessment, tariff, duty (including any customs duty), deficiency or fee, and any related charge or amount (including any fine, penalty or interest), imposed, assessed or collected by or under the authority of any Governmental Body.
 
“Warrants” shall mean any options, stock appreciation rights, warrants, convertible or exchangeable securities or other rights, contracts, commitments, agreements, understandings or arrangements of any kind relating to the issuance of any equity interests, or similar rights of an issuer or granting to any Person any right to participate in the equity or income of the issuer or to participate in or direct the election of any director or officer of the issuer or the manner in which any shares of capital stock or other securities of the issuer are voted, or other rights of any kind (absolute, contingent or otherwise) entitling any party to acquire or otherwise receive from the issuer any shares of capital stock or other securities or receive or exercise any benefits or rights similar to any rights enjoyed by or inuring to the holder of capital stock of the issuer, including without limitation “phantom stock” or stock appreciation rights. “Lime Warrants”
 
 
shall mean the foregoing definition as applied to Lime as the issuer and “Company Warrants” shall mean the foregoing definition as applied to the Company as the issuer.
 
ARTICLE 2
TRANSACTIONS AT THE CLOSING
 
     2.1 Purchase and Sale of Shares. Upon the terms and subject to the conditions set forth in this Agreement and in reliance upon the representations and warranties contained herein, at the Closing, each Seller shall sell and deliver to the Lime Purchaser the Shares owned by such Seller as set forth on Schedule A and the Lime Purchaser shall purchase the Shares free and clear of all Liens, for the Purchase Price determined in accordance with this Section 2.
 
     2.2 Purchase Price. The consideration (the “Purchase Price”) to be paid by the Lime Purchaser to each Seller for its Shares shall be a number of Lime Shares as reflected on Schedule A.
 
     2.3 Conditions to Closing. The closing of the Transaction (the “Closing”) is subject to (i) the representations and warranties contained in Articles 3, 4 and 5 being true and correct at and as of the Closing Date (as defined below) as if made or given on and as of the Closing Date; (ii) Lime shall have been afforded access to information as provided in Section 6.3; and (iii) Lime shall have obtained the Required Approval and it shall have become effective pursuant to Section 14(c) of the Exchange Act.
 
     2.4 Closing. The Closing shall take place at the offices of Reed Smith LLP, 10 S. Wacker Drive, Chicago Illinois 60606, or at such other place as the Company shall designate in writing to Sellers. Lime shall provide Sellers with at least five (5) business days’ notice in advance of the closing date (the “Closing Date”), which notice shall identity the Lime Purchaser and shall include a certification by Lime’s Chief Executive Officer that the Required Approval has been obtained and become effective pursuant to Section 14(c) of the Exchange Act. At the Closing, the Sellers shall convey and deliver to the Lime Purchaser stock certificates representing all of the Shares, duly endorsed in blank or accompanied by stock powers duly executed in blank, against payment of the Purchase Price for the Shares, as provided in Section 2.2, and Lime, on behalf of the Lime Purchaser, shall deliver to each Seller the Lime Shares indicated on Schedule A.
 
ARTICLE 3
REPRESENTATIONS AND WARRANTIES CONCERNING THE COMPANY
 
     Sellers’ Representative hereby represents and warrants to Lime, as of the date hereof and as of the Closing Date:
 
     3.1 Organization. The Company is a corporation, validly existing and in good standing under the laws of the State of Delaware and has all corporate power and authority to own, lease, and operate its properties and to carry on its business as it is now being conducted. To the best knowledge of Sellers’ Representative, the Company is duly organized under the laws of the State of Delaware and has all necessary governmental approvals to own, lease, and operate its properties and to carry on its business as it is now being conducted. Sellers’ Representative has delivered to Lime complete and correct copies of the Organizational Documents, the stockholder record list, prepared by the Company’s transfer agent as of November 4, 2008 (the “Stock Ledger”) and originals or copies of minutes of director meetings and consents in lieu of meetings in possession of the Company since June 2004 (collectively, the “Minutes”). To the best knowledge of Sellers’ Representative, the Stock Ledger is complete, accurate and current and
 
 
the Minutes are complete, accurate and current in all material respects. The Company has no direct or indirect Subsidiaries.
 
    3.2 Capitalization; Title to Shares
 
          (a) The Company’s authorized capital stock consists solely of 2,000,000,000 shares of Company Common Stock and 20,000,000 shares of preferred stock. The Shares represent at least ninety percent (90%) of the issued and outstanding shares of Company Common Stock. As of the date hereof (i) 1,167,621,940 shares of Company Common Stock are issued and outstanding, and (ii) 832,378,060 shares of Company Common Stock are held by the Company as non-voting treasury shares. No preferred stock is issued and outstanding. All outstanding shares of Common Stock are and will on the Closing Date be validly issued, fully paid and non-assessable.
 
          (b) To the best knowledge of Sellers’ Representative, (i) Schedule 3.2(b) is a true and complete list as of the date hereof, and as of the Closing Date, of all issued and outstanding Warrants, the number of shares of Company Common Stock subject to each such Warrant, and the name of each Warrant holder; and (ii) except as set forth on Schedule 3.2(b), there are no outstanding Warrants.
 
          (c) To the best knowledge of Sellers’ Representative: (i) the Company has not issued any securities in violation of any preemptive or similar rights; (ii) except for 109,902,680 shares of Company Common Stock reserved for issuance upon exercise of Warrants, there are no shares of capital stock or other securities of the Company reserved for issuance for any purpose; and (iii) the Company is not a party to any voting agreements, voting trusts, proxies or other agreements, instruments or understandings with respect to the voting of any shares of the capital stock or other securities of the Company, or any agreement with respect to the transferability, purchase or redemption of any shares of capital stock or other securities of the Company.
 
     3.3 Company SEC Reports. To the best knowledge of Sellers’ Representative, as of their respective dates, the Company SEC Reports:  (a) were prepared in accordance and complied in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, applicable to such Company SEC Reports; and (b) did not at the time they were filed (and if amended or superseded by a filing, then on the date of such filing and as so amended or superseded) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
 
     3.4 Company Changes. To the best knowledge of Sellers’ Representative, except as set forth on Schedule 3.4 or disclosed in the SEC Reports, other than any loans made by the Company to Lime, since December 31, 2007, there have not been: (a) any transactions by the Company, or any changes in the assets or liabilities of the Company, which, either individually or in the aggregate, are material to the financial condition of the Company; (b) any changes in the accounting practices, depreciation or amortization policies or rates theretofore adopted by any of the Company, or any revaluation of any of its assets; (c) the entry into any material contract or other binding obligation with any party other than Lime which is not immediately terminable by the Company without penalty; (d) any declaration, setting aside or payment of any dividend (whether in cash, stock or property) with respect to the Company Common Stock, or any other distribution to the stockholders of the Company, whether of record or beneficial other than in the ordinary course of business; (e) any amendment to the Organizational Documents of the Company; (f) the issuance or repricing of any Warrants with respect to Company Common Stock; (g) any reclassification of shares of Company Common Stock; (h) the authorization, issuance or reservation of any shares of capital stock of the Company; (i) any new, or changes in any, Tax election or method of
 
 
accounting for Tax purposes; or (j) any agreement by the Company to do any of the things described in the preceding clauses.
 
     3.5 Full Disclosure. To the best knowledge of Sellers’ Representative, no written information furnished by Sellers’ Representative to Lime in connection with this Agreement contains, as of the date of such written information, any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
 
     3.6 Litigation. To the best knowledge of Sellers’ Representative, there is no litigation, claim, proceeding, or governmental investigation pending or threatened against the Company or the Sellers that seeks to delay or prevent the consummation of, or which would be reasonably likely to adversely affect the Sellers’ ability to consummate, the Transaction.
 
ARTICLE 4
REPRESENTATIONS AND WARRANTIES OF EACH SELLER
 
Each Seller represents and warrants to Lime, for himself and not on behalf of any other Seller, as of the date hereof and as of the Closing Date as follows:
 
     4.1 Authority; No Conflict.
 
          (a) Seller has all necessary individual power, capacity and authority to execute and deliver this Agreement, to perform Seller’s obligations hereunder, and to consummate the Transaction. This Agreement has been duly and validly executed and delivered by Seller and constitutes the legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, subject to the effect of (i) applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect relating to rights of creditors generally and (ii) rules of law and equity governing specific performance, injunctive relief and other equitable remedies.
 
          (b) Neither the execution and delivery of this Agreement nor the performance thereof do or will, directly or indirectly (with or without notice or lapse of time or both), (i) contravene, conflict with, or result in a violation of any Legal Requirements to which the Seller, or any of the Seller’s Shares, are subject; or (ii) contravene, conflict with, or result in a violation or breach of any provision of, or give any Person the right to declare a default or exercise any remedy under, or to accelerate the maturity or performance of, or to cancel, terminate, or modify, any contract to which the Seller is a party, except, in the case of clauses (i) and (ii), for any such conflicts, violations, breaches, defaults or other occurrences that would not prevent the Seller from performing Seller’s obligations under this Agreement in any material respect.
 
          (c) The execution and delivery of this Agreement by the Seller does not, and the performance of this Agreement will not, require any Consent of, or filing with or notification to, any Governmental Body, except (i) for applicable requirements, if any, of the Exchange Act, the Securities Act and state securities or “blue sky” laws (“Blue Sky Laws ”), and (ii) such other Consents, filings or notifications where failure to obtain such Consents, or to make such filings or notifications, would not prevent the Seller from performing his, her or its obligations under this Agreement.
 
     4.2 Ownership. Seller owns, beneficially or of record, the number of Shares set forth opposite the Seller’s name on Schedule A hereto, free and clear of any and all Liens or other restrictions on transfer, other than those arising under the Exchange Act, the Securities Act, Blue Sky Laws and other
 
 
securities laws. Except as set forth on Schedule 3.2(b), Seller does not own any Warrants of the Company other than the Shares.
 
     4.3 Access to Information. Seller has had an opportunity to review this Agreement with assistance of counsel and other advisors of Seller’s own choosing.
 
     4.4 Review of Lime SEC Reports. Seller has had access to the Lime SEC Reports and the Company SEC Reports and has had an opportunity to review the Lime SEC Reports and the Company SEC Reports with assistance of counsel
and other advisors of Seller’s own choosing. Seller and Seller’s advisors have been afforded the opportunity to ask questions of and receive answers from Lime regarding Lime and the Lime SEC Reports.
 
ARTICLE 5
REPRESENTATIONS AND WARRANTIES OF LIME
 
Lime represents and warrants to the Sellers as of the date hereof and as of the Closing Date as follows:
 
     5.1 Organization and Good Standing. Lime is a corporation duly organized, validly existing, and in good standing under the laws of its jurisdiction of incorporation, with full corporate power and authority to conduct its business as now being conducted, to own or use its properties and assets that it purports to own or use, and to perform all of its obligations under contracts to which Lime is party or by which Lime or any of its assets are bound. Lime is duly qualified to do business as a foreign corporation and is in good standing (where such concept is applicable) under the laws of each state or other jurisdiction in which either the ownership or use of the properties owned or used by it, or the nature of the activities conducted by it, requires such qualification, except where the failure to be so qualified could not reasonably be expected to, individually or in the aggregate, result in a material adverse effect on Lime.
 
     5.2 Authority; No Conflict.
 
          (a) Other than obtaining the Required Approval: (i) Lime has all necessary corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder; (ii) the execution and delivery of this Agreement by Lime have been duly and validly authorized by all necessary corporate action and no other corporate proceedings on the part of Lime are necessary to authorize this Agreement; (iii) this Agreement has been duly and validly executed and delivered by Lime and, assuming the due execution and delivery of this Agreement by the Sellers, constitutes the legal, valid and binding obligation of Lime, enforceable against Lime in accordance with its terms subject to the effect of (A) applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect relating to rights of creditors generally, and (B) rules of law and equity governing specific performance, injunctive relief and other equitable remedies.
 
          (b) The execution and delivery of this Agreement does not and will not, directly or indirectly (with or without notice or lapse of time or both); (i) contravene, conflict with, or result in a violation of any provision of the Organizational Documents of Lime, or (ii) contravene, conflict with, or result in a violation of, any Legal Requirement.
 
          (c) The execution and delivery of this Agreement by Lime does not require any Consent of, or filing with or notification to, any Governmental Body, except (i) for applicable requirements, if any, of the Exchange Act, the Securities Act, the Marketplace Rules, and Blue Sky Laws, and (ii) such other Consents, filings or notifications where failure to obtain such Consents, or to make
 
 
such filings or notifications, would not prevent Lime from performing its obligations under this Agreement in any material respect.
 
     5.3 Capitalization. The authorized capital stock of Lime consists of 200,000,000 shares of Lime Common Stock and 1,000,000 shares of Series A-1 Convertible Preferred Stock, US $0.01 par value per share (“Lime Preferred Stock”). As of the date hereof, (a) 9,555,053 shares of Lime Common Stock are issued and outstanding, all of which are duly authorized, validly issued, fully paid and nonassessable, (b)  546,424 shares of Lime Common Stock are reserved for issuance upon exercise of outstanding Warrants, and (c) 358,710 shares of Lime Preferred Stock are issued and outstanding, all of which are duly authorized, validly issued, fully paid and nonassessable. Lime has accepted subscription agreements for another 933,049 shares of Lime Common Stock and for Warrants to purchase 233,263 shares of Lime Common Stock, and such shares and warrants will be issued prior to the Closing in accordance with the terms of the subscription agreements.
 
     5.4 Availability of Common Stock. Lime has authorized but unissued shares of Lime Common Stock in an amount sufficient to consummate the Transaction.
 
     5.5 Lime SEC Reports. As of their respective dates, the Lime SEC Reports: (a) were prepared in accordance and complied in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, applicable to such Lime SEC Reports, and (b) did not at the time they were filed (and if amended or superseded by a filing, then on the date of such filing and as so amended or superseded) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
 
     5.6 Absence of Certain Changes. Except as described in that certain Written Consent in Lieu of Meeting, executed by the stockholders of Lime on November 13, 2008, a copy of which has previously been delivered to Sellers, since September 30, 2008, there has not been any change which by itself or in conjunction with all other such changes, has had or could reasonably be expected to have a material adverse effect, except as disclosed in the Lime SEC Reports.
 
     5.7 Full Disclosure. No written information furnished by Lime to Sellers in connection with this Agreement contains, as of the date of such written information, any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
 
     5.8 Litigation. There is no litigation, claim, proceeding, or governmental investigation pending or threatened against Lime that seeks to delay or prevent the consummation of, or which would be reasonably likely to adversely affect the Lime’s ability to consummate, the Transaction.
 
ARTICLE 6
ADDITIONAL AGREEMENTS
 
     6.1 No Company Changes. From the date hereof through the Closing Date, each Seller who is a director or officer of the Company agrees that such Seller will not, directly or indirectly, as a stockholder, director or officer of the Company, take or permit to occur any action or inaction which could result in any of the representations and warranties set forth in Article 3 to be no longer true in all material respects.
 
 
     6.2 Required Approval. Lime agrees to use its reasonable best efforts to obtain the consent of a majority of its stockholders and to file the Information Statement on or before February 1, 2009 for the purpose of obtaining the Required Approval, and each Seller agrees to vote or cause to be voted all shares of Lime Common Stock and Lime Preferred Stock over which Seller has voting power in favor of such action.
 
     6.3 Due Diligence. From the date hereof through the Closing Date, Sellers’ Representative agrees to give, and to cause the Company to give, Lime, its counsel, accountants and other representatives access to the properties, books, records, contracts and documents of the Company for purpose of such inspection as Lime deems appropriate, and shall furnish or cause to be furnished to Lime and its representatives all information with respect to the business and affairs of the Company as Lime may request.
 
     6.4 Market Standoff. From the date hereof through the Closing Date or date of termination of this Agreement, if applicable, each Seller hereby agrees not to sell, offer to sell, contract to sell (including, without limitation, any short sale), grant any option to purchase, pledge or otherwise transfer or dispose of (other than to donees who agree to be similarly bound) any Lime Common Stock or Company Common Stock beneficially owned by such Seller.
 
     6.5 Other Company Stockholders. Following the Closing Date, Lime will offer or otherwise effect to the remaining stockholders of the Company an exchange of Lime Common Stock for their shares of Company Common Stock at the Exchange Ratio.
 
     6.6 General Release. Effective upon the Closing Date:
 
          (a) Each Seller, for Seller and Seller’s heirs, devisees, legal representatives, successors, and assigns (each, a “Releasing Party” and, collectively, the “Releasing Parties”), does hereby acknowledge complete satisfaction of and does hereby fully, finally, and forever release and discharge each of the Company and its directors and officers (collectively, the “Released Parties”) of and from any and all commitments, actions, debts, claims, counterclaims, suits, causes of action, damages, demands, liabilities, obligations, costs, expenses, and compensation of every kind or nature whatsoever, past, present, or future, at law or in equity, whether known or unknown, contingent or otherwise, which such Releasing Parties, or any of them, had, has, or may have had at any time in the past and through and including the Closing Date, against the Released Parties, or any of them, which relate to or arise out of such Releasing Party’s relationship with the Company or any of its predecessors or Affiliates, or such Releasing Party’s rights or status as a stockholder of the Company or any of its predecessors or Affiliates, and further including, without limitation, any claims of fraud or fraudulent inducement in connection with the negotiation, execution, delivery, and performance of this Agreement (collectively, the “Causes of Action”); provided, however, that nothing in this Section shall release, acquit, or discharge any Causes of Action or preclude a lawsuit or claim in respect of any Causes of Action that a Releasing Party may have or bring arising under this Agreement or the other documents and agreements executed and delivered pursuant to this Agreement, or that a Releasing Party may have or bring arising under his respective Indemnification Agreement or the bylaws of the Company, or any other rights of indemnification or constitution of law or in equity.
 
          (b) Each Releasing Party represents, warrants, covenants, and agrees that such Releasing Party (a) has not and will not assign any Causes of Action or possible Causes of Action against any Released Party, (ii) fully intends to release all Causes of Action against the Released Parties, including, without limitation, unknown and contingent Causes of Action (other than those specifically reserved above), and (iii) has consulted with counsel with respect to the matters covered hereby and has been fully apprised of the consequences hereof.
 
 
          (c) Each Releasing Party covenants and agrees not to institute any litigation, lawsuit, claim, or action against any of the Released Parties with respect to any released Causes of Action.
 
     6.7 Best Efforts. As soon as practicable, Lime shall commence and continue in good faith to take all reasonable action required to obtain all consents, approvals and agreements of, and to give all notices to and make all filings with, any third parties, including Governmental Authorities, necessary or appropriate to authorize, approve or permit the full and complete consummation of the Transaction and the Merger. In addition, Lime shall use its best efforts to take, or cause to be taken, all action or do, or cause to be done, all things necessary, proper or advisable under this Agreement, applicable laws and regulations to enable, consummate, make effective and evidence the Transaction and the Merger.
 
     6.8 Directors’ and Officers’ Insurance and Indemnification.
 
          (a) Continuation of Existing Indemnification. Lime agrees that all rights to indemnification now existing or hereafter arising at or prior to the Closing in favor of the directors or officers of the Company as provided in its Certificate of Incorporation or Bylaws as in effect on the date hereof or pursuant to the Indemnification Agreements in effect on the date hereof shall survive the Closing and shall continue in full force and effect for a period of not less than six years from the Closing; provided, however, that in the event any claim or claims are asserted or made within such six year period, all rights to indemnification in respect of any such claim or claims shall continue until final disposition of any and all such claims. After the Closing, Lime shall continue to perform the obligations of the Company under the Indemnification Agreements. Without limiting the foregoing, in the event that any party covered by existing indemnification protection becomes involved in any capacity in any action, proceeding or investigation in connection with any matter, including the transactions contemplated hereby, occurring prior to, and including, the Closing, Lime shall periodically advance to such party its legal and other expenses (including the cost of any investigation and preparation incurred in connection therewith), provided that such funds advanced shall be promptly returned to the Company in the event it shall be judicially determined that such party is not entitled to indemnification by the Company or Lime.
 
          (b) Cooperation. In the event any action, suit, proceeding or investigation challenging this Agreement or the ability of the parties hereto to consummate the Transaction is commenced by a third party, whether before or after the Closing, Lime and the Sellers’ Representative agree (except for matters involving any breach of an Article 4 representation, in which chase the applicable Seller agrees) to cooperate and use all reasonable efforts to defend against and respond thereto.
 
     6.9 Indemnity of Sellers. Each Seller makes no representation or warranty regarding and shall have no responsibility for (a) the truth or accuracy of any information with respect to or supplied by Lime, or any of its Affiliates (except for information supplied in writing by such Seller) contained in the Information Statement or the Registration Statement or any amendment or supplement thereto, or (b) the conformance of the Information Statement with the requirements of the Exchange Act and other applicable law, or (c) the conformance of the Registration Statement with the requirements of the Securities Act and other applicable law. With respect to such information, and in addition to the obligations under Section 6.8 above, Lime shall indemnify each Seller, director and officer of the Company as of the date hereof (collectively, the "Indemnified Party”), against any (i) losses, claims, damages or liabilities, joint or several, and amounts paid in any settlement approved by Lime (which approval shall not be unreasonably withheld or delayed) in connection with the foregoing, to which any of such persons may be subject, and (ii) legal or other expenses reasonably incurred by such persons in connection with investigating or defending against any such losses, claims, damages or liabilities insofar as such losses, claims, damages or liabilities are caused by (A) any untrue statement or alleged untrue statement of a material fact contained in the Information Statement or Registration Statement, or any
 
 
amendment or supplement thereto, (B) arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, (C) the failure of the Information Statement to comply with the requirements of the Exchange Act and other applicable law, or (D) the failure of the Registration Statement to comply with the requirements of the Securities Act and other applicable law. This indemnity shall be payable as incurred and on demand. Each person entitled to be indemnified pursuant to this Section 6.9 shall give notice to Lime in writing promptly after obtaining knowledge of any claim or litigation for which indemnity may be had hereunder, but failure to do so shall not affect the right to indemnity hereunder. Lime shall only be obligated under this Section to pay the costs and expenses of one counsel for the Indemnified Parties as a group. If the indemnification provisions above are unavailable or insufficient to hold harmless the Indemnified Party in respect of any losses, claims, damages, or liabilities, then Lime shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect the relative fault of such Indemnified Party, on the one hand, and Lime, on the other hand.
 
     6.10 Notification of Certain Matters.
 
          (a) Lime shall give prompt notice to the Sellers’ Representative of (i) the occurrence, or failure to occur, of any event which occurrence or failure to occur would be likely to cause any representation or warranty made by Lime in this Agreement to be untrue or inaccurate in any material respect at any time from the date hereof to the Closing; (ii) any notice of, or other communication relating to, a default or event which, with notice or lapse of time or both, would become a default, received by Lime prior to the Closing, under any agreement, indenture or instrument to which Lime or any of its subsidiaries is a party or is subject which default would materially and adversely affect the ability of Lime to perform its obligations hereunder and to effect the Closing; (iii) any notice or other communication from any third party received by Lime alleging that the consent of such third party is or may be required in connection with the transactions contemplated by this Agreement; and (iv) any notice or other communication from any regulatory authority received by Lime in connection with the Transaction or the Merger.
 
          (b) Sellers’ Representative shall give prompt notice to Lime (i) upon Seller’s Representative obtaining knowledge of the occurrence, or failure to occur, of any event which occurrence or failure to occur would be likely to cause any representation or warranty made by any Seller in this Agreement to be untrue or inaccurate in any material respect at any time from the date hereof to the Closing; (ii) of any notice of, or other communication relating to, a default or event which, with notice or lapse of time or both, would become a default, received by Sellers’ Representative prior to the Closing, under any agreement, indenture or instrument to which any Seller is a party or is subject which default would materially and adversely affect the ability of such Seller to perform Seller’s obligations hereunder and to effect the Closing; (iii) of any notice or other communication from any third party received by Sellers’ Representative alleging that the consent of such third party is or may be required in connection with the transactions contemplated by this Agreement; and (iv) of any notice or other communication from any regulatory authority received by Sellers’ Representative in connection with the Transaction or the Merger .
 
     6.11 Company Patents. Lime shall maintain in effect, for a period of not less than one (1) year following the Closing, the Company patents set forth in Schedule 6.11.
 
     6.12 Company Warrants. Notwithstanding any provisions to the contrary in the Company Warrants which may provide for expiration or cancellation on a change of control or merger of the Company, Lime agrees to offer (the
 
“Warrant Offer”) to each Company Warrant holder the right to exchange such holder’s Company Warrants for new Lime Warrants to acquire such number of shares of
 
 
Lime Common Stock as such holder would have received had the holder exercised the Company Warrant in full prior to the Merger. Any such new Warrant will have an aggregate exercise price equal to the aggregate exercise price under the applicable Company Warrant, shall have the same expiration date as the applicable Company Warrant, and shall otherwise be in form and substance reasonably acceptable to Sellers’ Representative. The Warrant Offer shall be transmitted to each Warrant holder within 30 days following the Closing together with the form of the new Lime Warrant. Copies of each Warrant Offer and form of new Lime Warrant shall also be provided to Sellers’ Representative.
 
     6.13 No Legal Actions. Lime shall, and Sellers’ Representative shall cause the Company to, execute contemporaneously with the execution hereof, a general release and agreement (the "General Release”) in substantially the form attached hereto as Exhibit 1. The General Release shall constitute a separate agreement, the consideration for which shall be the agreement of each Seller to approve and execute this Agreement and the General Release shall survive the expiration or other termination of this Agreement.
 
     6.14 Appointment of Board of Directors. Within ten (10) days following the Closing, Lime shall use its best efforts to cause Christopher W. Capps to be appointed as a director of Lime. Unless otherwise notified by Richard P. Kiphart, for so long as Richard P. Kiphart shall own any of the capital stock of Lime, Lime shall use its best efforts to cause Mr. Capps to be nominated as a director for each election of directors, unless Mr. Capps shall have resigned or been removed in accordance with Delaware law.
 
     6.15 Registration Statement. Lime shall prepare and file a registration statement with the SEC under the Securities Act on Form S-4, registering the Lime Common Stock to be issued in connection with the Merger (the “Registration Statement”), no later than December 31, 2008. Thereafter, Lime shall use its best efforts to cause such Registration Statement to be declared effective as soon as possible. Without limiting the foregoing, Lime will promptly respond to all SEC comments, inquiries and requests.
 
     6.16 Merger. Lime shall effect the Merger within forty-five (45) days following the Closing, or, if later, within 5 business days after the effectiveness of the Registration Statement. Among the terms of the Merger, the separate corporate existence of the Company will terminate and each of the outstanding shares of Company Common Stock not already owned by Lime shall be, at the Company stockholder’s election, converted into shares of Lime Common Stock at the Exchange Ratio set forth on Schedule B or converted into the right to receive cash at the rate of $0.008625 per share.
 
     6.17 Reports under Exchange Act. With a view to making available to the Sellers the benefits of Rule 144 under the Securities Act, or any other similar rule or regulation of the SEC that may at any time permit the Sellers to sell the Lime Shares to the public without registration (“Rule 144”), Lime agrees to: (a) make and keep adequate current public information available, within the meaning of Rule 144; (b) file with the SEC in a timely manner all reports and other documents required of Lime under the Securities Act and the Exchange Act so long as Lime remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and (c) furnish to each Seller so long as such Seller owns any Lime Shares, promptly upon request (i) a written statement by Lime, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (ii) a copy of or free online access to the most recent Lime SEC Reports, and (iii) such oher information as may reasonably be requested by a Seller in order to sell Lime Shares pursuant to Rule 144 without registration.
 
 
ARTICLE 7
SURVIVAL; INDEMNIFICATION
 
     7.1 Survival.
 
          (a) The representations, warranties, covenants, and agreements of the Sellers made herein and in all agreements, documents, and instruments executed and delivered by each Seller in connection herewith (i) are material, shall be deemed to have been relied upon by Lime, and shall survive the execution hereof regardless of any investigation on the part of Lime or its Representatives, with Lime reserving its rights hereunder, and (ii) shall bind each Seller’s successors and assigns, whether so expressed or not, and shall inure to the benefit of Lime and its respective successors and assigns.
 
          (b) The representations and warranties of the parties made herein and in all agreements, documents, and instruments executed and delivered by any party in connection herewith shall expire and be of no further force or effect on March 31, 2009, except that any written claim for breach thereof made prior to such expiration date and delivered to the party against whom such claim is made shall survive thereafter and, as to any such claim, such applicable expiration will not effect the rights to indemnification of any party hereunder; provided, however, that any such written claim with respect to fraud, intentional misrepresentation or willful breach, may be given at any time.
 
     7.2 Indemnification.
 
          (a) Indemnification by the Sellers. Each Seller acknowledges and agrees that Lime has relied on the representations, warranties, covenants and other agreements of such Seller contained in this Agreement. Accordingly, each Seller, on his/her/its own behalf and on behalf of his/her/its Seller’s successors, executors, administrators, estate, heirs and assigns (collectively, the “Stockholder Indemnifying Parties”) agrees to severally defend, indemnify and hold Lime, its directors, officers, employees and agents (collectively, the “Lime Indemnified Parties”) harmless from and against any and all Losses as the same are incurred, of any kind or nature whatsoever (whether or not arising out of third-party claims) which may be sustained or suffered by any such Lime Indemnified Party based upon, arising out of, or by reason of (i) any breach of any representation or warranty made by such Seller in this Agreement; (ii) any breach of any covenant or agreement made by such Seller in this Agreement, and (iii) the inaccuracy or incompleteness of any information provided to Lime in writing by such Seller and stated specifically to be used for inclusion in the Information Statement or the Registration Statement.
 
          (b) Notice; Payment of Losses; Defense of Third-Party Claims.
 
     (i) With respect to any claim for indemnification based on breach of any covenant or agreement made by the Sellers in this Agreement, and as to which there is no third party claim, Lime shall notify Sellers’ Representative of such breach and claim, which notice shall provide reasonable detail as to the alleged breach and Sellers’ Representative shall have ten (10) business days to effect a cure of such breach. If such cure cannot be effected, or if the Sellers’ Representative contests such breach, the parties shall proceed with the claim for indemnification as provided in Section 7.2(b)(iii) below.
 
     (ii) For all indemnification claims other than those provided for in Section 7.2(b)(i) above, a Lime Indemnified Party shall give written notice of a claim for indemnification to the applicable Stockholder Indemnifying Party promptly after receipt of any written claim by any third party and in any event not later than twenty (20) business days after receipt of any such
 
 
written claim (or not later than ten (10) business days after the receipt of any such written claim in the event such written claim in the form of a formal complaint filed with a court of competent jurisdiction and served on the Lime Indemnified Party or in the form of a final determination by any Governmental Body); provided, however, that failure to give such notice shall not limit the right of the Lime Indemnified Party to recover indemnity or reimbursement except to the extent that the Stockholder Indemnifying Party suffers any material prejudice or material harm with respect to such claim as a result of such failure. The Lime Indemnified Party shall provide the Stockholder Indemnifying Party with such further information concerning any such claims as the Stockholder Indemnifying Party may reasonably request by written notice.
 
     (iii) Within ten (10) business days after receiving notice of a claim for indemnification or reimbursement, the Stockholder Indemnifying Party shall, by written notice to the Lime Indemnified Party, either (i) concede or deny liability for the claim in whole or in part, or (ii) in the case of a claim asserted by a third party, advise that the matters set forth in the notice are, or will be, subject to contest or legal proceedings not yet finally resolved. If the Stockholder Indemnifying Party concedes liability in whole or in part, it shall, within twenty (20) business days of such concession, pay the amount of the claim to the Lime Indemnified Party to the extent of the liability conceded. Any such payment shall be made in immediately available funds equal to the amount of such claim so payable. If the Stockholder Indemnifying Party denies liability in whole or in part or advises that the matters set forth in the notice are, or will be, subject to contest or legal proceedings not yet finally resolved, then the Stockholder Indemnifying Party shall make no payment (except for the amount of any conceded liability payable as set forth above and reimbursement of expenses as set forth herein) until the matter is resolved in accordance with this Agreement.
 
     (iv) In the case of any third party claim, if, within ten (10) business days after receiving the notice described in the preceding paragraph (a), the Stockholder Indemnifying Party gives written notice to the Lime Indemnified Party stating that the Stockholder Indemnifying Party would be liable under the provisions hereof for indemnity in the amount of such claim if such claim were valid and that the Stockholder Indemnifying Party disputes and intends to defend against such claim, liability or expense at the Stockholder Indemnifying Party’s own cost and expense, then, except as provided below, counsel for the defense shall be selected by the Stockholder Indemnifying Party (subject to the consent of such Lime Indemnified Party which consent shall not be unreasonably withheld) and such Stockholder Indemnifying Party shall not be required to make any payment to such Lime Indemnified Party with respect to such claim, liability or expense as long as the Stockholder Indemnifying Party is conducting a good faith and diligent defense at its own expense; provided, however, that the assumption of defense of any such matters by the Stockholder Indemnifying Party shall relate solely to the claim, liability or expense that is subject or potentially subject to indemnification. If the Stockholder Indemnifying Party assumes such defense in accordance with the preceding sentence, it shall have the right, with the consent of such Lime Indemnified Party, which consent shall not be unreasonably withheld, to settle all indemnifiable matters related to claims by third parties which are susceptible to being settled provided the Stockholder Indemnifying Party’s obligation to indemnify such Lime Indemnified Party therefor will be fully satisfied only by payment of money by the Stockholder Indemnifying Party pursuant to a settlement which includes a complete release of such Lime Indemnified Party. The Stockholder Indemnifying Party shall keep such Lime Indemnified Party apprised of the status of the claim, liability, or expense and any resulting suit, proceeding or enforcement action, shall furnish such Lime Indemnified Party with all documents and information that such Lime Indemnified Party shall reasonably request, and shall consult with such Lime Indemnified Party prior to acting on major matters, including settlement discussions. Notwithstanding anything herein stated, such Lime Indemnified Party shall at all
 
 
times have the right to fully participate in such defense at its own expense directly or through counsel; provided, however, if the named parties to the action or proceeding include both the Stockholder Indemnifying Party and such Lime Indemnified Party and representation of both parties by the same counsel would be inappropriate under applicable standards of professional conduct as set forth in a reasoned written opinion issued by counsel for such Lime Indemnified Party, the reasonable expense of separate counsel for such Lime Indemnified Party shall be paid by the Stockholder Indemnifying Party. If (A) no such notice of intent to dispute and defend is given by the Stockholder Indemnifying Party, or if such diligent good faith defense is not being or ceases to be conducted, or (B) the third party claim relates to breaches of representations and warranties made by a Stockholder Indemnifying Party that relate to the Company, its business or operations, Lime may undertake the defense of such claim, liability, or expense at the Stockholder Indemnifying Party’s own cost and expense (with counsel selected by Lime), and shall have the right to compromise or settle, such claim, liability, or expense (exercising reasonable business judgment). If such claim, liability, or expense is one that by its nature cannot be defended solely by the Stockholder Indemnifying Party, then such Lime Indemnified Party shall make available all information and assistance that the Stockholder Indemnifying Party may reasonably request and shall cooperate with the Stockholder Indemnifying Party in such defense.
 
          (c) Limitation on Contribution and Certain Other Rights. Each Seller hereby agrees that if, following the Closing Date, any Losses become due from such Seller pursuant to this Section 7.2 (a “Loss Payment ”), such Seller shall have no rights against Lime, the Company or any of their directors, officers or employees (in their capacity as such), whether by reason of contribution, indemnification, subrogation or otherwise, in respect of any such Loss Payment, and each Seller shall not take any action against Lime or any such Person with respect thereto.
 
          (d) Limitations. The aggregate liability of each Seller under Section 7.2 shall not exceed an amount equal to the number of shares of Company Common Stock sold by such Seller multiplied by $0.008625, together with the value of any Lime Warrants received by such Seller pursuant to Section 6.12.
 
ARTICLE 8
MISCELLANEOUS PROVISIONS
 
     8.1 Fees, Expenses and Taxes. Lime shall pay the fees and expenses of Rutter Hobbs & Davidoff Incorporated, as counsel for the Sellers’ Representative, in connection with this Agreement and the Transaction. All other fees, expenses and Taxes incurred in connection with this Agreement and the Transaction shall be paid by the party incurring such fees, expenses, or Taxes. Lime and the Sellers understand that the Transaction is a taxable event to the Sellers and agree that the Transaction is not intended to be a tax-free reorganization.
 
     8.2 Termination. This Agreement shall terminate by mutual agreement of Lime and the Sellers’ Representative or if the Closing has not occurred by March 31, 2009. Upon termination of this Agreement no party shall have any liability to any other party, unless the reason for termination is that the Closing has failed to occur due to a breach of a party’s obligations hereunder.
 
     8.3 Amendment. This Agreement may not be amended, except by an instrument in writing signed by or on behalf of Lime and the Sellers’ Representative.
 
 
     8.4 Waiver.
 
          (a) Neither any failure nor any delay by any party in exercising any right, power or privilege under this Agreement or any of the documents referred to in this Agreement will operate as a waiver of such right, power or privilege and no single or partial exercise of any such right, power or privilege will preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege. To the maximum extent permitted by Legal Requirements, (i) no waiver that may be given by a party will be applicable except in the specific instance for which it is given; and (ii) no notice to or demand on one party will be deemed to be a waiver of any obligation of that party or of the right of the party giving such notice or demand to take further action without notice or demand as provided in this Agreement or the documents referred to in this Agreement.
 
          (b) At any time prior to the Closing Date, Lime (with respect to the Sellers) and the Sellers’ Representative (with respect to Lime), may, to the extent legally allowed, (i) extend the time for the performance of any of the obligations or other acts of such other party to this Agreement, (ii) waive any inaccuracies in the representation and warranties contained in this Agreement or any document delivered pursuant to this Agreement and (iii) waive compliance with any covenants, obligations or conditions contained in this Agreement. Any agreement on the part of a party to this Agreement to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party.
 
     8.5 Entire Agreement. This Agreement and the documents and instruments and other agreements among the parties hereto as contemplated by or referred to herein constitute the entire agreement among the parties to this Agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof.
 
     8.6 Execution of Agreement; Counterparts; Electronic Signatures.
 
          (a) This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument, and shall become effective when counterparts have been signed by each of the parties and delivered to the other parties; it being understood that all parties need not sign the same counterpart.
 
          (b) The exchange of copies of this Agreement and of signature pages by facsimile transmission (whether directly from one facsimile device to another by means of a dial-up connection or whether mediated by the worldwide web), by electronic mail in “portable document format”(“.pdf” format), or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, or by a combination of such means, shall constitute effective execution and delivery of this Agreement as to the parties and may be used in lieu of an original Agreement for all purposes. Signatures of the parties transmitted by facsimile shall be deemed to be their original signatures for all purposes.
 
     8.7 Governing Law. Except to the extent that the corporate laws of the State of Delaware apply to a party, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Illinois, regardless of the laws that might otherwise govern under applicable principles of conflicts of law thereof.
 
     8.8 Consent to Jurisdiction; Venue. In any action or proceeding between Lime and any of the Sellers arising out of or relating to this Agreement or the Transaction, each of the parties: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of any state or federal court located in the City of Chicago, Illinois (each, a “Chicago Court ”); and (b) agrees
 
 
that all claims in respect of such action or proceeding may be heard and determined exclusively in any Chicago Court. Each of the parties hereto agrees that a final judgment in any such action or proceeding and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.
 
     8.9 WAIVER OF JURY TRIAL. EACH OF THE PARTIES IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING BETWEEN THE PARTIES ARISING OUT OF OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
 
     8.10 Attorneys’ Fees. In any action at law or suit in equity to enforce this Agreement or the rights of any of the parties hereunder, and except as provided in Section 7 and Section 8.1 , the prevailing party in such action or suit shall be entitled to receive a reasonable sum for its attorneys’ fees and all other reasonable costs and expenses incurred in such action or suit.
 
     8.11 Assignments and Successors. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties hereto and their respective successors and assigns; provided, however, that neither this Agreement nor any of the Sellers’ rights hereunder may be assigned by any Seller without the prior written consent of Lime, provided the assignment of rights by any Seller to the Sellers’ Representative shall not require any such consent.. Any attempted assignment of this Agreement or of any such rights by any Seller without such consent shall be void and of no effect.
 
     8.12 No Third Party Rights. Except for the persons referenced in Sections 6.4, 6.6, 6.8, 6.9, 6.12, 6.13, and 6.14 who are intended third party beneficiaries of such Sections and this Agreement, nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the parties hereto) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.
 
     8.13 Notices. All notices, Consents, waivers and other communications required or permitted by this Agreement shall be in writing and shall be deemed given to a party when (a) delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); or (b) sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment confirmed with a copy delivered as provided in clause (a), in each case to the following addresses or facsimile numbers and marked to the attention of the person (by name or title) designated below (or to such other address, facsimile number, e-mail address or person as a party may designate by notice to the other parties) between the hours of 9:00 a.m. and 5:00 p.m. in the recipient’s time zone:
 
If to Lime:
 
Lime Energy Co.
1280 Landmeier Road
Elk Grove Village, Illinois 60007-2410
Attention: Jeffrey R. Mistarz
Fax no.: (847) 437-4969
 
with a copy to:
 
Reed Smith LLP
10 S. Wacker Drive
Chicago, Illinois 60606-7507
 
 
Attention: Evelyn Arkebauer
Fax no.: (312) 207-6400
 
If to any Seller, to the Sellers’ Representative and counsel on behalf of the Sellers’ Representative:
 
Richard P. Kiphart
William Blair & Co.
222 W. Adams Street
Chicago, Illinois 60606
Fax no.: (312) 368-9418
 
with a copy to:
 
Rutter Hobbs & Davidoff Incorporated
1901 Avenue of the Stars, Suite 1700
Los Angeles, CA 90067-6018
Attention: Joel Weinstein
Fax no.: (310) 286-1728
 
     8.14 Legal Representation of the Parties . This Agreement was negotiated by the parties with the benefit of legal representation and any rule of construction or interpretation otherwise requiring this Agreement to be construed or interpreted against any party shall not apply to any construction or interpretation hereof.
 
     8.15 Enforcement of Agreement. Except as otherwise expressly provided herein, any and all remedies herein expressly conferred upon a party hereunder shall be deemed cumulative with and not exclusive of any other remedy conferred hereby or by law on such party, and the exercise of any one remedy shall not preclude the exercise of any other. The parties acknowledge and agree that each other party hereunder would be irreparably damaged if any of the provisions of this Agreement are not performed in accordance with their specific terms and that any breach of this Agreement by a party hereunder could not be adequately compensated in all cases by monetary damages alone. Accordingly, in addition to any other right or remedy to which a party hereunder may be entitled, at law or in equity, it shall be entitled to enforce any provision of this Agreement by a decree of specific performance and temporary, preliminary and permanent injunctive relief to prevent breaches or threatened breaches of any of the provisions of this Agreement, without posting any bond or other undertaking.
 
     8.16 Severability. If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.
 
     8.17 Appointment of Sellers’ Representative. Each Seller hereby irrevocably authorizes and appoints Richard P. Kiphart (the “Sellers’ Representative”) as such Seller’s representative and attorney-in-fact to act in the capacity contemplated by this Agreement. If the Sellers’ Representative or any successor shall resign, die or become unable to act as Sellers’ Representative, a replacement shall be promptly appointed by a writing signed by Sellers who hold a majority of the Shares being sold hereby, which replacement shall thereafter be the Sellers’ Representative with the same powers and duties as the previous Sellers’ Representative. Sellers’ Representative shall not be liable to any Seller or any other person for anything which he may do or refrain from doing in connection with this Agreement except in the event of fraud, or willful misconduct by Sellers’ Representative. In connection with the exercise of his
 
duties, Sellers’ Representative will be entitled to consult with and rely upon legal counsel and other professional advisors, with the costs thereof to be allocated among the Sellers, and Sellers’ Representative will have no liability hereunder for actions taken in good faith reliance upon the advice of such advisors.
 
 
     8.18 Sellers (other than Sellers’ Representative) shall, jointly and severally, indemnify Sellers’ Representative for, and hold him harmless against, any Losses arising out of or in connection with his duties as Sellers’ Representative including the cost and expenses of defending himself against any Losses, except for Losses arising from the fraud or willful misconduct of Sellers’ Representative.
 
[ Remainder of page intentionally left blank – signature pages follow ]
-18A-
 
 
SIGNATURE PAGE
TO
STOCK PURCHASE AGREEMENT
LIME ENERGY CO. AND SELLERS (listed on Schedule A)
LIME:
 
Lime Energy Co.
         
By:
  /s/ Jeffrey Mistarz    
 
 
Jeffrey Mistarz 		   
  Executive Vice President and CFO    
 
SELLERS:
 
For completion by Seller who is a natural person:
     
 
Signature
   
 
    
 
Print Name
   
 
    
For completion by Seller who is not a natural person (trust, partnership, etc.):
 
    
 
Print Name of Entity
   
         
By:
        
 
 
    
     
 
Print Name and Title
   
- -19-
EX-2 3 v133549_ex2.htm Unassociated Document
EXHIBIT 2
 
JOINT FILING AGREEMENT
 
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.001, of Advanced Biotherapy, Inc., a Delaware corporation, and further agrees that this Joint Filing Agreement be included as an exhibit to such filings. As contemplated by Section 13d-1(k)(1)(ii), no person shall be responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Joint Filing Agreement may be executed in any number of counterparts, all of which together shall constitute one and the same instrument.
 
Dated as of November 25, 2008

/s/ Richard P. Kiphart
Signature
 
Name/Title: Richard P. Kiphart
 
/s/ Michael P. Krasny, Trustee
Signature
 
Name/Title: Michael P. Krasny, Trustee of the Michael P. Krasny Revocable Trust
 
/s/ Simon Skurkovich
Signature
 
Name/Title: Simon Skurkovich, M.D.
 
/s/ Rebecca S. Kiphart
Signature
 
Name/Title: Rebecca S. Kiphart
 
/s/ Julia K. Gluck
Signature
 
Name/Title: Julia K. Gluck
 
/s/ John R. Capps
Signature
 
 
Name/Title: John R. Capps
 
/s/ Mathew Gooch
Signature
 
Name/Title: Matthew Gooch
 
/s/ David W. Valentine
Signature
 
Name/Title: David W. Valentine
 
/s/ Christopher W. Capps
Signature
 
Name/Title: Christopher W. Capps
 
/s/ Boris Skurkovich
Signature
 
Name/Title: Boris Skurkovich, M.D.
 
/s/ Carol Dorros
Signature
 
Name/Title: Carol Dorros, M.D.
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----